- Rating
- 1
- Confidence
- 4
- Informativeness
- 1
- Presentation
- 2
- Soundness
- 1
Read review
Paper summary
The paper proposes GeneSyn-HGNN for drug synergy prediction. It integrates a motif-guided multi-relational hypergraph encoder and a structured cell-conditioned decoder. The decoder consists of cell-conditioned gating, gene-synergy kernel, and gene-selective attention. Experiments on O’Neil and NCI-ALMANAC datasets demonstrate it has some improvements over the selected baselines.
Critical strengths
None
Critical weaknesses
- Unjustified problem simplification and baseline choices. The drug synergy prediction problem is simplified as a binary classification problem. Recent baselines are reviewed but not included in the performance comparison, such as TensoGraph (March 2026, Open access with code released).
- Lack of novelty. The proposed method is incremental and it doesn't provide sufficient value to either graph learning or drug synergy prediction research community.
Questions for authors
- Why do you formulate the drug synergy prediction as a binary classification problem? Is it useful in real applications?
- Why baselines like TensoGraph is reviewed yet omitted in the performance comparison? New researches like Cosynllm is also missing.
- Are there any theoretical support on the design of GSK? How do we further advance the research of drug synergy prediction and graph learning based on the findings presented in the paper?